Menu Search
Equities

ZoomMed Inc

ZMD.H:NEX

ZoomMed Inc

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2018.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year ZoomMed Inc grew revenues 3,951.93% from 11.15k to 451.79k while net income improved from a loss of 1.23m to a gain of 175.45k.
Gross margin--
Net profit margin943.16%
Operating margin943.16%
Return on assets14,863.23%
Return on equity--
Return on investment--
More ▼

Cash flow in CADView more

In 2023, cash reserves at ZoomMed Inc fell by 3.86k. However, Cash Flow from Investing totalled 487.50k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 335.70k for operations while cash used for financing totalled 155.66k.
Cash flow per share0.0114
Price/Cash flow per share1.40
Book value per share-0.0014
Tangible book value per share-0.0014
More ▼

Balance sheet in CADView more

ZoomMed Inc uses little or no debt in its capital structure.
Current ratio0.0467
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.